Currently, the share price for Dr. Lalchandani Labs Ltd. is delayed. Login to view live prices.
Dr. Lalchandani Labs Ltd.
₹19.00
BSE
-- ( -- %) 1D
Earnings Per Share
Earnings Per Share (EPS) is calculated by dividing a company’s net income by its average number of outstanding shares.
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
Particulars (In Cr) | Mar 2024 | Y/Y Change |
---|---|---|
Operating Revenue | 2.08 | -- |
Other Income | 0.24 | -- |
Total Income | 2.32 | -- |
Total Expenditure | 2.23 | -- |
EBIDT | 1.28 | -- |
Depreciation | 0.29 | -- |
Interest | 0.28 | -- |
Tax | 0.00 | -- |
Net Profit | 0.71 | -- |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Particulars (In Cr) | Mar 2024 | Y/Y Change |
---|---|---|
Total Current Assets | 9.48 | -13.97% |
Total Non-Current Assets | 5.51 | -17.76% |
Fixed assets | 3.99 | -25.97% |
Total assets | 14.99 | -15.41% |
Total Current Liabilities | 5.03 | -5.45% |
Total Non-Current Liabilities | 0.42 | -87.93% |
Total Capital Plus Liabilities | 14.99 | -15.41% |
Total Shareholder Funds | 9.54 | +6.95% |
Total Debt to Equity | 0.36 | -32.08% |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Particulars (In Cr) | Mar 2024 | Y/Y Change |
---|---|---|
Cash from Operating Activity | -0.22 | -- |
Cash from Financing Activities | -1.59 | +591.30% |
Cash from Investing Activities | 1.00 | -626.32% |
Net Cash Flow | -0.81 | +88.37% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer